Literature DB >> 17348911

Occurrence and characterization of verocytotoxigenic Escherichia coli (VTEC) strains from dairy farms in Trinidad.

R R Roopnarine1, D Ammons, J Rampersad, A A Adesiyun.   

Abstract

A cross-sectional study was conducted to determine the prevalence and characteristics of verocytotoxigenic Escherichia coli (VTEC) on 25 dairy farms each located in Waller field and Carlsen field farming areas in Trinidad. On each selected farm, faecal samples were collected from milking cows, calves and humans; rectal swabs were obtained from pet farm dogs; bulk milk was sampled as well as effluent from the milking parlour. Escherichia coli was isolated from all sources on selective media using standard methods. Isolates of E. coli were subjected to slide agglutination test using E. coli O157 antiserum, vero cell cytotoxicity assay to detect verocytotoxin (VT) and heat labile toxin (LT) production, the polymerase chain reaction (PCR) to detect VT genes, and the dry spot test to screen for E. coli O157 and non-O157 strains. In addition, faecal samples from animal and human sources were tested for VT genes using PCR. Of a total of 933 E. coli isolates tested by the slide test, eight (0.9%) were positive for the O157 strain. The vero cell cytotoxicity assay detected VT-producing strains of E. coli in 16.6%, 14.6%, 3.2% and 7.1% of isolates from cows, calves, farm dogs and humans respectively (P < 0.05; chi(2)). For LT production, the highest frequency was detected amongst isolates of E. coli from calves (10.8%) and the lowest (0.0%) amongst isolates from humans and bulk milk (P < 0.05; chi(2)). Of the 61 VT-producing isolates by vero cell cytotoxicity assay tested by PCR, the VT, LT and eae genes were detected in 62.3%, 4.9% and 1.6% respectively (P < 0.05; chi(2)). Amongst the 45 E. coli isolates that were VT positive (vero cell) or VT-gene positive by PCR, 2.2%, 2.2%, 4.4% and 6.7% belonged to non-O157 strains O91, O111, O103 and O157, respectively, as determined by the Dry spot test. Detection of VTEC strains in milk and dairy animals poses a health risk to consumers of milk originating from these farms. In addition, the demonstration of VTEC strains in humans, VT gene in faecal samples and E. coli isolates as well as non-O157 VTEC strains of E. coli are being documented for the first time in the country.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17348911     DOI: 10.1111/j.1863-2378.2007.01024.x

Source DB:  PubMed          Journal:  Zoonoses Public Health        ISSN: 1863-1959            Impact factor:   2.702


  6 in total

1.  Characterization of Shiga toxin-producing Escherichia coli (STEC) in feces of healthy and diarrheic calves in Urmia region, Iran.

Authors:  Saei H Dastmalchi; N Ayremlou
Journal:  Iran J Microbiol       Date:  2012-06

2.  Prevalence of Farm and Slaughterhouse Workers Carrying Shiga Toxin-Producing Escherichia coli in Korea.

Authors:  Sahyun Hong; Seung Eun Song; Kyung Hwan Oh; Seung Hak Kim; Seok Ju Yoo; Hyun Sul Lim; Mi Sun Park
Journal:  Osong Public Health Res Perspect       Date:  2011-12

Review 3.  Recent Updates on Outbreaks of Shiga Toxin-Producing Escherichia coli and Its Potential Reservoirs.

Authors:  Jun-Seob Kim; Moo-Seung Lee; Ji Hyung Kim
Journal:  Front Cell Infect Microbiol       Date:  2020-06-04       Impact factor: 5.293

Review 4.  A Review of Current Research and Knowledge Gaps in the Epidemiology of Shiga Toxin-Producing Escherichia coli and Salmonella spp. in Trinidad and Tobago.

Authors:  Anil K Persad; Jeffrey LeJeune
Journal:  Vet Sci       Date:  2018-04-17

Review 5.  An overview of food safety and bacterial foodborne zoonoses in food production animals in the Caribbean region.

Authors:  Maria Manuela Mendes Guerra; Andre M de Almeida; Arve Lee Willingham
Journal:  Trop Anim Health Prod       Date:  2016-05-23       Impact factor: 1.559

6.  Molecular characterization of pathogenic Escherichia coli isolated from diarrheic and in-contact cattle and buffalo calves.

Authors:  Walid S Awad; Amr A El-Sayed; Faten F Mohammed; Noha M Bakry; Nadra-Elwgoud M I Abdou; Mohamed S Kamel
Journal:  Trop Anim Health Prod       Date:  2020-07-10       Impact factor: 1.893

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.